Board Certification:

• American Board of Internal Medicine, Board Certification in Cardiovascular Disease
• American Board of Internal Medicine, Board Certification in Internal Medicine

Society Memberships:

• Fellow of The American College of Cardiology
• Member, American Society of Nuclear Cardiology
• Member, American Society of Echocardiography
• Member, American College of Physicians
• Member, Citrus County Medical Society

Experience:

• Physician, Citrus Cardiology Consultants
• Chief of Medicine, Citrus Memorial Hospital
• Medical Director, Cardiac Catheterization Laboratories

Research Experience:

• Sub-Investigator - The Effect of LDL-Cholesterol Lowering Beyond Currently Recommended Minimum Targets on Coronary Heart Disease (CHD) Recurrence in Patients with Pre-Existing CHD, The TNT Trial. 981-117/258-102 Parke Davis and Pfizer, Inc.
• Sub-Investigator - The Diabetic CHF Trial: A 6 Month, Double Blind, Placebo Controlled, Multicenter Study of Troglitazone (CI-991) in Patients with Type II Diabetes and Congestive Heart Failure. Parke Davis Pharmaceuticals.
• Sub-Investigator - The ALIVE Trial: A Double Blind, Placebo Controlled, Parallel Design Study to Determine the Effect of 75 or 100 mg of Orally Administered Azimilide Dyhydrochloride versus Placebo on Survival in Recent Post Myocardial Infarction Patients at Risk of Sudden Death. Proctor & Gamble.
• Principal Investigator - OVERTURE: Omapatrillat Versus Enalapril Randomized Trial of Utility in Reducing Events. Bristol Myers Squibb.
• Principal Investigator - SPORTIF V - A Phase III, Multicenter, Randomized, Double Blind, Two Arm, Parallel Group Study Comparing the Effects of Melagatran vs. a Dose-Adjusted Vitamin K Antagonist (comparator). AstraZeneca.
• Sub-Investigator - PROVE IT-TIMI 22: Pravastatin Or Atorvastatin Evaluation and Infection Therapy. Bristol Myers Squibb.
• Sub-Investigator - SAFE: Silent Atrial Fibrillation Detection with Stored EGMs. Guidant.
• Principal Investigator - IMPACT: The Impact of Medical Subspecialty on Patient Compliance to Treatment. Kos Pharmaceuticals/DuPont Pharmaceuticals, Inc.

Education & Training:

• FACC
• Chief Cardiology Fellow - Millard Fillmore Hospital/SUNYAB
• Adult Cardiology Fellowship - Millard Fillmore Hospital/SUNYAB
• Internal Medicine Residency - Millard Fillmore Hospital/SUNYAB
• 5th Pathway - Rotating Internship - SUNYAB
• Top 10% of Graduating Class - Autonoma University of Guadalajara
• Autonoma University of Guadalajara
• BS-Zoology - George Washington University

Licensure:

• New York State Medical License - #173909 (inactive)
• Florida State Medical License - #0059443

Appointments:

• Clinical Instructor in Medicine - SUNYAB
• Clinical Assistant Instructor in Medicine - SUNYAB